Showing results (1291-1300 of 1,337) with videos related to
Sort By:
Pageof 134
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 28, 2009
Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) virusesB C Ciancio, T J Meerhoff, P Kramarz, et al.Nature Nanotechnology|November 7, 2009
True solutions of single-walled carbon nanotubes for assembly into macroscopic materialsVirginia A Davis, A Nicholas G Parra-Vasquez, Micah J Green, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 26, 2022
Exocrine pancreas insufficiency in chronic pancreatitis - Risk factors and associations with complications. A multicentre study of 1869 patientsFriedemann Erchinger, Trond Engjom, Georg Dimcevski, et al.Journal of Neurosurgery|April 11, 2020
Predictors of ventriculostomy infection in a large single-center cohortAhmad Sweid, Joshua H Weinberg, Rawad Abbas, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 30, 2019
Pancreatic calcifications associate with diverse aetiological risk factors in patients with chronic pancreatitis: A multicentre study of 1500 casesSøren S Olesen, Maria Valeryevna Lisitskaya, Asbjørn M Drewes, et al.Scientific Reports|May 15, 2023
A hybrid multi-particle approach to range assessment-based treatment verification in particle therapyIlker Meric, Enver Alagoz, Liv B Hysing, et al.The American Journal of Gastroenterology|February 12, 2019
Chronic Pancreatitis Is Characterized by Distinct Complication Clusters That Associate With Etiological Risk FactorsSøren S Olesen, Camilla Nøjgaard, Jakob L Poulsen, et al.NEJM Evidence|June 3, 2026
Secukinumab for Giant Cell ArteritisJohn H Stone, Nils Venhoff, Frank Buttgereit, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2024
Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled TrialKathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, Tobias Todsen, et al.Lung Cancer (Amsterdam, Netherlands)|November 30, 2007
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)Elizabeth A Johnson, Randolph S Marks, Sumithra J Mandrekar, et al.Pageof 134